Creightons Plc

Operating both within the United Kingdom and across international markets, Creightons Plc, along with its subsidiaries, specializes in the development, manufacturing, and marketing of a wide array of personal care items and fragrances. Their diverse product portfolio covers categories such as hair care, skin care, bath and body essentials, wellbeing solutions, and male grooming products. In addition to offering their own branded goods, the company provides private label manufacturing for major high street retailers and supermarket chains, and undertakes contract manufacturing for other brand owners. Their extensive brand family includes popular lines like Argan Smooth, Balance Active Formula, Creightons Frizz No More, Feather & Down, and The Curl Company, among many others. Customers also have the convenience of purchasing these products through online platforms. Established in 1954, Creightons Plc maintains its headquarters in Peterborough, UK.

Creightons Plc trades as CRL.L on LSE. The company is classified in Consumer Defensive / Household & Personal Products and reports in GBP.

The current profile places the business in Household & Personal Products. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £54.07M of revenue and £2.45M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Creightons Plc can be compared against peers such as The Artisanal Spirits Company plc, Northcoders Group PLC, Dekel Agri-Vision plc, Malvern International Plc, Revolution Beauty Group plc, MicroSalt Plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £14.73M, beta of 0.65, and return on equity of +10.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CRL.L currently shows total debt of £3.25M and beta of 0.65. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.creightons.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.